American Association for Cancer Research (AACR)
-
Publisher Of
-
Mitigating SOX2-potentiated Immune Escape of Head and Neck Squamous Cell Carcinoma with a STING-inducing Nanosatellite Vaccine.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research.
24:4242-4255.
2018
-
CD47 Blockade as an Adjuvant Immunotherapy for Resectable Pancreatic Cancer.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research.
24:1415-1425.
2018
-
Recurrent Mutations of Chromatin-Remodeling Genes and Kinase Receptors in Pheochromocytomas and Paragangliomas.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research.
22:2301-2310.
2016
-
Abstract A38: Identification through functional genomics screening of factors whose downregulation enhances the side population in ovarian cancer..
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research.
22:A38-A38.
2016
-
Abstract A68: Sphingosine kinase 1 as a mediator and predictor of metformin's protective effect in ovarian cancer..
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research.
22:A68-A68.
2016
-
Abstract B27: Investigation of small GTPase genes in epithelial ovarian cancer..
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research.
22:B27-B27.
2016
-
Abstract A092: Surpassing the emerging immune-checkpoint inhibitor market.
Cancer Immunology Research.
4:A092-A092.
2016
-
Abstract A157: Oncolytic poliovirus mediated immune events.
Cancer Immunology Research.
4:A157-A157.
2016
-
Abstract B140: Overall survival of metastatic melanoma patients treated with HD IL-2 followed by immune checkpoint blockade of the CTLA-4 or the PD-1 pathways: Analysis of data on the current use of HD IL-2.
Cancer Immunology Research.
4:B140-B140.
2016
-
Abstract B38: p90RSK mediates resistance to PI3K-pathway inhibitors in breast cancer.
Molecular Cancer Therapeutics.
14:B38-B38.
2015
-
Abstract A30: Using the principles of community-based participatory research to build an office of health equity within a nationally designated cancer institute.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
23:A30-A30.
2014
-
Abstract B22: Altered methylation profiles of imprinted genes in response to prenatal exposure to cigarette smoke in the Newborn Epigenetic STudy (NEST) cohort.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
23:B22-B22.
2014
-
Abstract C16: Feasibility study: Protein profiling of primary breast cancers from premenopausal women.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
23:C16-C16.
2014
-
Abstract IA08: Ataxia-telangiectasia: Broad implications from the study of a rare disease.
Cancer Research.
74:IA08-IA08.
2014
-
Abstract P1-08-20: Increased risk of hormone therapy failure in breast cancers expressing low phospho-Stat5: Validation of quantitative immunofluorescence assay parameters.
Cancer Research.
73.
2013
-
Abstract P4-06-03: Assays on core biopsies and surgically resected tumors may result in different subtyping of the invasive breast cancer from the same patient.
Cancer Research.
73.
2013
-
Abstract P4-06-09: HER2+ and HER2- luminal B subtypes have similar overall survival and histologic grade distributions.
Cancer Research.
73.
2013
-
Abstract P4-15-05: Novel targeted therapy for breast cancer chest wall recurrence: Low temperature liposomal doxorubicin and mild local hyperthermia.
Cancer Research.
73.
2013
-
Abstract P5-08-01: Systematic interrogation of resistance to HER2-directed therapy identifies a survival pathway activated by PRKACA and PIM1.
Cancer Research.
73.
2013
-
S100A14: Novel Modulator of Terminal Differentiation in Esophageal Cancer.
Molecular Cancer Research : Mcr.
11:1542-1553.
2013
-
Abstract B151: Monitoring tumor microenvironment (Hb saturation and oxygenation) in response to plasmonics-assisted photothermal cancer therapy..
Molecular Cancer Therapeutics.
12:B151-B151.
2013
-
Abstract C248: Novel PORCN inhibitors are safe and effective in the treatment of WNT-dependent cancers..
Molecular Cancer Therapeutics.
12:C248-C248.
2013
-
Abstract C61: Phase I Study of pazopanib in combination with the investigational hypoxia-targeted drug TH-302..
Molecular Cancer Therapeutics.
12:C61-C61.
2013
-
Abstract C85: Drug interaction study of tivantinib in cancer subjects using a cocktail approach..
Molecular Cancer Therapeutics.
12:C85-C85.
2013
-
Abstract A83: Induction of PD-L1 expression by cytotoxic agents through activation of NF-kB signal.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research.
19:A83-A83.
2013
-
Abstract B19: Functional genomics approach links anchorage-independence with tumor dormancy in ovarian cancer.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research.
19:B19-B19.
2013
-
Abstract PR08: HNF1β confers resistance to oxidative stress of ovarian clear cell carcinoma.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research.
19:PR08-PR08.
2013
-
Abstract A18: Genetic elements of cancer cell survival in tumor microenvironment stresses.
Molecular Cancer Therapeutics.
12:A18-A18.
2013
-
Abstract 2409: A model of RAS pathway in colorectal cancer elucidates molecular traits and drug sensitivity: an integrated analysis of gene expression from human tumors, mouse xenografts and the Cancer Cell Line Encyclopedia (CCLE)..
Cancer Research.
73:2409-2409.
2013
-
Abstract 4517: Differential cellular response to nanoparticle docetaxel and docetaxel at sub-therapeutic dose range..
Cancer Research.
73:4517-4517.
2013
-
Abstract 4522: Nanoparticle chemosensitization..
Cancer Research.
73:4522-4522.
2013
-
Abstract 4530: Nanoparticle formulation of KU55933 as a potent radiosensitizer..
Cancer Research.
73:4530-4530.
2013
-
Abstract PR3: The cholesterol metabolite 27-hydroxycholesterol increases breast cancer tumor growth and metastasis.
Cancer Research.
73:PR3-PR3.
2013
-
Abstract A29: An Ad5 [E1-, E2b-] platform carrying the TAA CEA(6D) induces CEA directed CMI responses in patients with advanced CEA-expressing colorectal cancer in a phase I/II clinical trial...
Cancer Research.
73:A29-A29.
2013
-
Abstract P2-10-03: A cross-platform comparison of genomic signatures and OncotypeDx score to discover potential prognostic/predictive genes and pathways.
Cancer Research.
72.
2012
-
Abstract P3-06-07: Ki67 as a Predictive Marker of Response to Neoadjuvant Chemotherapy in Patients with Early-Stage Breast Cancer (ESBC): A Systematic Review and Evidence Summary.
Cancer Research.
72.
2012
-
Abstract P4-08-07: Novel insight into the tumor “flare” phenomenon and lapatinib resistance.
Cancer Research.
72.
2012
-
Abstract P4-14-04: Total skin-sparing mastectomy in BRCA mutation carriers.
Cancer Research.
72.
2012
-
Abstract P4-16-07: Selective use of post-mastectomy radiation therapy in the neoadjuvant setting.
Cancer Research.
72.
2012
-
Cross-talk between HER2 and MED1 Regulates Tamoxifen Resistance of Human Breast Cancer Cells.
Cancer Research.
72:5625-5634.
2012
-
Abstract 1369: Mouse models of clinical oligo- and poly-metastatic progression.
Cancer Research.
72:1369-1369.
2012
-
Abstract 1678: European ancestry and ovarian cancer: Testing for their association using case control data.
Cancer Research.
72:1678-1678.
2012
-
Abstract 2012: MAP kinase activation and suppression of anti-apoptotic Bcl-2 family members are associated with induction of apoptotic death in melanoma cells following down-regulation of glutathione S-transferase P1.
Cancer Research.
72:2012-2012.
2012
-
Abstract 2162: EGFR-induced interaction of GSTP1 with the SH2-domain of Grb2 enhances Ras downstream activation in human glioma cells.
Cancer Research.
72:2162-2162.
2012
-
Abstract 2603: Subtype-specific ovarian cancer risk associated with SNPs in IL1A.
Cancer Research.
72:2603-2603.
2012
-
Abstract 2884: Preclinical studies on tumor retention, antitumor efficacy and toxicity of thermally responsive polypeptide-based radionuclide intratumoral depot in nude mice.
Cancer Research.
72:2884-2884.
2012
-
Abstract 2923: Androgen receptor activation changes chromatin structure and transcriptional activation.
Cancer Research.
72:2923-2923.
2012
-
Abstract 3035: Bone morphogenetic proteins signal through Smad2 and Smad3 to regulate cell migration and proliferation.
Cancer Research.
72:3035-3035.
2012
-
Abstract 3220: The effects of cholesterol treatment drugs alone and in combination on prostate tumor xenograft growth.
Cancer Research.
72:3220-3220.
2012
-
Abstract 3405: MicroRNA expression characterizes oligometastasis(es).
Cancer Research.
72:3405-3405.
2012
-
Abstract 381: Non-invasive histology for early detection of cutaneous melanoma and pigmented lesions in vivo.
Cancer Research.
72:381-381.
2012
-
Abstract 4311: EphB2 receptor controls proliferation/migration dichotomy of glioblastoma by interacting with focal adhesion kinase.
Cancer Research.
72:4311-4311.
2012
-
Abstract 4389: Impact of regulatory T cell depletion on dendritic cell-tumor fusion vaccine immunotherapy.
Cancer Research.
72:4389-4389.
2012
-
Abstract 4514: A comparison of two methodologies to quantify Thymidylate synthase for predicting survival in patients with colorectal cancer treated on CALGB 89803.
Cancer Research.
72:4514-4514.
2012
-
Abstract 4812: p53 acts during total-body irradiation to promote lymphomagenesis.
Cancer Research.
72:4812-4812.
2012
-
Abstract 4958: Identification of cis-regulatory elements in a BIM deletion polymorphism that regulate splicing and generation of non-apoptotic BIM isoforms.
Cancer Research.
72:4958-4958.
2012
-
Abstract 5123: An integrated genomics approach to identify novel drivers of oncogenic pathway activity in human cancer.
Cancer Research.
72:5123-5123.
2012
-
Abstract 530: Circulating γδ T cells are activated and depleted during progression of high-grade gliomas: Implications for γδ T cells therapy of GBM.
Cancer Research.
72:530-530.
2012
-
Abstract 5363: Aggregation rather than monoclonal expansion explains ovarian cancer spheroid formation.
Cancer Research.
72:5363-5363.
2012
-
Abstract LB-327: Validation of a breast cancer risk prediction model in African American women.
Cancer Research.
72.
2012
-
Abstract LB-76: Mibefradil, a novel therapy for glioblastoma: An interlaced therapy approach.
Cancer Research.
72.
2012
-
Abstract LB-87: Methylated-mediated repression of ZNF154
in ovarian cancer is associated with poor overall survival.
Cancer Research.
72.
2012
-
P1-01-15: Do Serum Cytokines Predict Breast Cancer Behavior?.
Cancer Research.
71.
2011
-
P1-06-24: Nuclear Localization of Stat5a Predicts Response to Antiestrogen Therapy and Prognosis of Clinical Breast Cancer Outcome..
Cancer Research.
71.
2011
-
P1-13-03: Zoledronic Acid Induces an Immune Response in Breast Cancer Patients through Stimulation of Central Memory and Effector Memory gamma/delta T-Cells..
Cancer Research.
71.
2011
-
P3-14-04: Assessment of Genomic Prognostic Signatures as Predictors of Response to Neoadjuvant Chemotherapy in Patients with Early Stage Breast Cancer..
Cancer Research.
71.
2011
-
Correction: Aggressive Fibromatosis (Desmoid Tumor) Is Derived from Mesenchymal Progenitor Cells.
Cancer Research.
71:6084-6084.
2011
-
Abstract 1635: Short hairpin RNA-mediated transcriptional suppression of glutathione S-transferase P1 suppresses growth and induces apoptosis through altered MAP kinase signaling in melanoma cells.
Cancer Research.
71:1635-1635.
2011
-
Abstract 2277: Loss of nuclear localized and tyrosine phosphorylated Stat5: A predictor of poor clinical outcome and increased risk of antiestrogen therapy failure in breast cancer.
Cancer Research.
71:2277-2277.
2011
-
Abstract 2337: Defining significance of the novel tGLI1 transcription factor in cancer growth and progression.
Cancer Research.
71:2337-2337.
2011
-
Abstract 2482: Bat3 facilitates histone H3 lysine 79 dimethylation by DOT1L to promote ionizing radiation-induced 53BP1 foci formation during G1- and G2-phases of the cell cycle.
Cancer Research.
71:2482-2482.
2011
-
Abstract 2754: Maternal use of antidepressants in pregnancy is associated with hypermethylation at the IGF2
imprinted control regions in the offspring in a race-dependent fashion.
Cancer Research.
71:2754-2754.
2011
-
Abstract 2767: Genetic variation in obesity-related genes ADBR2, ADBR3, GHRL, HSD11B1, and SHC1 and risk of prostate cancer: A VA case-control study.
Cancer Research.
71:2767-2767.
2011
-
Abstract 2817: An RNA aptamer is a potential biomarker for pancreatic cancer.
Cancer Research.
71:2817-2817.
2011
-
Abstract 3014: Quantitative accuracy of Illumina HumanMethylation27 Infinium BeadChip data assessed by pyrosequencing.
Cancer Research.
71:3014-3014.
2011
-
Abstract 3086: Interactions of nucleolin and ribosomal protein RPL26 in the translational control of human p53 mRNA.
Cancer Research.
71:3086-3086.
2011
-
Abstract 3311: IL6-Stat3 signaling promotes glioma stem cell (GSC) survival under hypoxia environment through inhibition of cell-death inducing gene Bnip3.
Cancer Research.
71:3311-3311.
2011
-
Abstract 4417: Characterization of xenograft-derived EGFRvIII-positive GBM cell cultures reveals functional interactions between EGFRvIII, wild-type EGFR, and p53.
Cancer Research.
71:4417-4417.
2011
-
Abstract 4602: Cholesterol and ezetimibe: Effects on tumor growth and survival outcomes: An interim analysis.
Cancer Research.
71:4602-4602.
2011
-
Abstract 4637: Intra-individual changes in circulating IGF-1 and IGF-1/IGFBP-3 molar ratio are associated with colorectal adenomatous polyps presence.
Cancer Research.
71:4637-4637.
2011
-
Abstract 4697: Metabolic regulation of caspase-2.
Cancer Research.
71:4697-4697.
2011
-
Abstract 5306: 18F-EF5 microPET imaging of treatment response from a novel, hypoxia-selective cytotoxin SN30000 in a human lung cancer xenograft model.
Cancer Research.
71:5306-5306.
2011
-
Abstract 615: PP2A activation as a strategy for treatment of breast cancer.
Cancer Research.
71:615-615.
2011
-
Abstract 703: GSTP1 inhibition of HSP27 phosphorylation contributes to glioma drug resistance.
Cancer Research.
71:703-703.
2011
-
Abstract LB-255: A mass spectrometry platform to quantitatively profile cancer cell metabolism from cells, tumors, and fixed tissue.
Cancer Research.
71.
2011
-
Abstract LB-454: Serum metabolic profiles and endometrial cancer.
Cancer Research.
71.
2011
-
Abstract P1-04-01: X-Linked Inhibitor of Apoptosis Protein (XIAP) Regulates TRAIL-Induced Apoptosis in Inflammatory Breast Cancer Cells.
Cancer Research.
70.
2010
-
Abstract P2-12-01: Is Cancer-Specific Distress Correlated with Time to Definitive Surgery in Breast Cancer Patients?.
Cancer Research.
70.
2010
-
Abstract 3971: The type III tgf-β receptor mediates bmp signaling in normal and cancerous mammary epithelial cells.
Cancer Research.
70:3971-3971.
2010
-
Abstract 4831: ATM signals to TSC2 in the cytoplasm to regulate mTORC1 and autophagy in response to ROS.
Cancer Research.
70:4831-4831.
2010
-
Abstract 5061: Induction of B cell acute lymphoblastic leukemia by BCR/ABL requires c-Myb and its activation of Bmi-1.
Cancer Research.
70:5061-5061.
2010
-
Abstract 5338: Metastatic colorectal cancer cells from patients previously treated with chemotherapy are sensitive to T cell killing mediated by CEA/CD3-bispecific T cell-engaging BiTE antibody.
Cancer Research.
70:5338-5338.
2010
-
Abstract LB-213: Plasma soluble VEGFR1 is a potential dual biomarker of response and toxicity for bevacizumab with chemoradiation in locally advanced rectal cancer.
Cancer Research.
70.
2010
-
The Role of microRNA-221 and microRNA-222 in Androgen-Independent Prostate Cancer Cell Lines.
Cancer Research.
69:3356-3363.
2009
-
Genome-Wide Impact of Androgen Receptor Trapped clone-27 Loss on Androgen-Regulated Transcription in Prostate Cancer Cells.
Cancer Research.
69:3140-3147.
2009
-
Abstract SS02-02: A long walk from FGFR2 alternative splicing to cancer progression.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
23.
2014
-
Abstract P1-22-02: Subsequent risk of ipsilateral breast events in a multinational DCIS cohort of 48.619 patients: A meta-analysis within the PRECISION consortium.
Cancer Research.
2022
-
Abstract P2-08-08: Concurrent predictors of an immune responsive tumor microenvironment within tumor mutational burden-high breast cancer.
Cancer Research.
2022
-
Abstract P4-10-06: Best quality care from a distance (BQual-D): Maintaining high quality care for hormone receptor positive (HR+) metastatic breast cancer (MBC) during the COVID pandemic, description of the program and provider satisfaction.
Cancer Research.
2022
-
Abstract P5-13-29: Analytical and clinical validation of a ctDNA assay for detecting copy number loss and structural rearrangement variants contributing to homologous recombination and repair (HRR) deficiency.
Cancer Research.
2022
-
Abstract PO-107: Racial differences in survival among advanced-stage non-small cell lung cancer patients who received immunotherapy: An analysis of the U.S. National Cancer Database (NCDB).
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
2022
-
Abstract PO-113: Overall survival in ovarian cancer patients seeking care at more than one treatment facility.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
2022
-
Abstract PO-137: Comparative transcriptomic analysis of prostate cancer from African American and Caucasian American men by Gleason score and race.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
2022
-
Abstract PO-178: Metabolic syndrome and risk of breast cancer by molecular subtype: Analysis of the Mechanisms for Novel and Established Risk Factors for Breast Cancer in Women of Nigerian Descent (MEND) study.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
2022
-
Abstract PO-183: Racial disparities in Helicobacter pylori
infection: A systematic review and retrospective study.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
2022
-
Abstract PO-232: Racial differences in the tumor immune landscape and survival of high-grade serous ovarian carcinoma.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
2022
-
Abstract PO-271: Racial and ethnic disparities in human papillomavirus (HPV) vaccine uptake among adults aged 27-45 years in the United States.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
2022
-
Abstract 101: The Tanzanian Pediatric Cancer Network: A Comprehensive Evaluation of the Incidence of Presenting Patients and Access to Pediatric Cancer Care in Tanzania.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
101-101.
2021
-
Abstract 102: Breakpoints in Protocol Compliance and Their Influence on Outcomes for Children with Wilms Tumor in Northern Tanzania.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
102-102.
2021
-
Abstract 112: Use of WhatsApp to Improve Medical Provider Communication for Children with Wilms Tumor in Tanzania.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
112-112.
2021
-
Abstract 4: Impact of Immunohistochemistry on Diagnostic Accuracy for Pediatric Cancer in Tanzania.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
4-4.
2021
-
Abstract 1180: Estimating the contribution of epidemiologic risk factors to racial differences in epithelial ovarian cancer incidence.
Cancer Research.
1180-1180.
2020
-
Abstract 2033: Reducing cancer caregiver burden: A user-centered design approach for an mHealth app.
Cancer Research.
2033-2033.
2020
-
Abstract 2327: Genetic correlation analysis identifies glioma heritability enrichment in immune cell types and novel protective associations with auto-immune conditions.
Cancer Research.
2327-2327.
2020
-
Abstract 3507: Race-related genetic variation and response to secondary hormonal therapy in metastatic castration-resistant prostate cancer.
Cancer Research.
3507-3507.
2020
-
Abstract 3511: Racial differences in circulating mitochondria-derived peptides may contribute to prostate cancer health disparities.
Cancer Research.
3511-3511.
2020
-
Abstract 3882: YAP1 and WWTR1 (TAZ) positively regulate PAX3-FOXO1 transcriptional programming in fusion-positive rhabdomyosarcoma.
Cancer Research.
3882-3882.
2020
-
Abstract 5243: Averting tumor growth in rodent breast cancer models with a liquid ablation approach.
Cancer Research.
5243-5243.
2020
-
Abstract 5719: Tumor-suppressive stromal activity of pro-fibrogenic microRNA-21 in initiation and progression of K-Ras-driven mouse models of pancreatic cancer.
Cancer Research.
5719-5719.
2020
-
Abstract 5821: The role of SMARCAL1
loss-of-function mutations in glioblastoma telomere maintenance.
Cancer Research.
5821-5821.
2020
-
Abstract 6406: FAK and MEK co-targeting: A new multimodal precision therapy for GNAQ
-driven uveal melanoma.
Cancer Research.
6406-6406.
2020
-
Abstract 6439: CapioCyte™ technology for efficient capture and downstream analysis of circulating tumor cells from renal cell carcinoma.
Cancer Research.
6439-6439.
2020
-
Abstract 6536: Safety and efficacy of autologous tumor lysate particle loaded dendritic cell (TLPLDC) vaccination in combination with systemic therapies in patients with metastatic melanoma.
Cancer Research.
6536-6536.
2020
-
Abstract 6630: Synergistic immuno photothermal nanotherapy (SYMPHONY) for combination cancer therapy.
Cancer Research.
6630-6630.
2020
-
Abstract 904: Stimulation and expansion of oncogene-reactive tumor infiltrating T cells through combined Ad-HER2Δ16 vaccination and anti-PD1 enable anti-tumor responses against established HER2 BC.
Cancer Research.
904-904.
2020
-
Abstract IA06: Dysregulated Hippo signaling in childhood rhabdomyosarcoma.
Molecular Cancer Research : Mcr.
IA06-IA06.
2020
-
Abstract A023: Results from a town hall meeting: Inflammatory breast cancer listening session led by KOMEN scholars.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
A023-A023.
2020
-
Abstract A038: Current unmet needs in inflammatory breast cancer/IBC patient care: Analysis of open-ended responses from a community engagement session of clinicians, researchers, advocates, and patients at the Duke Consortium for IBC conference.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
A038-A038.
2020
-
Abstract A066: Performance of the prostate health index (PHI) assay in black men.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
A066-A066.
2020
-
Abstract A076: Adherence to adjuvant endocrine therapy: Do racial disparities persist among the insured?.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
A076-A076.
2020
-
Abstract A080: Rates of Invitation, participation, and willingness to engage in medical and clinical research: Findings from attendees at two gender-specific community-based screening programs.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
A080-A080.
2020
-
Abstract A082: ENACT: A randomized trial assessing the impact of the Oncotype DX Prostate Cancer Assay on treatment decision in a racially diverse population of men eligible for active surveillance.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
A082-A082.
2020
-
Abstract A114: Characterization of a metastatic prostate cancer xenograft derived from a patient of African ancestry.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
A114-A114.
2020
-
Abstract A50: Circulating tumor DNA (ctDNA) and magnetic resonance imaging (MRI) for monitoring and predicting response to neoadjuvant therapy (NAT) in high-risk early breast cancer patients in the I-SPY 2 TRIAL.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research.
A50-A50.
2020
-
Abstract B006: Development of a novel therapeutic splice-switching oligonucleotide targeting race-related androgen receptor signaling and aggressive prostate cancer.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
B006-B006.
2020
-
Abstract B034: Improving patient-centered care for inflammatory breast cancer: Strategies for addressing barriers faced by patients, researchers, and providers.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
B034-B034.
2020
-
Abstract B035: Identification of a tumor cell adaptive stress response signaling pathway, which drives aggressive breast cancer phenotype and therapeutic resistance, in African American patients with locally advanced breast cancer subtypes.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
B035-B035.
2020
-
Abstract B050: Identification of differentially expressed and spliced genes between breast, colon, lung, and prostate cancer from African American and white patients.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
B050-B050.
2020
-
Abstract B061: Mechanistic and functional interrogation of novel ancestry-related alternatively spliced androgen receptor signal genes in prostate cancer.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
B061-B061.
2020
-
Abstract B063: Race-related LMO7
exon skipping enhances prostate tumor invasion.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
B063-B063.
2020
-
Abstract B064: Race-related genetic variation and response to secondary hormonal therapy in metastatic castration-resistant prostate cancer.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
B064-B064.
2020
-
Abstract B071: Genomic differences between non-small cell lung cancer (NSCLC) in African American and white patients.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
B071-B071.
2020
-
Abstract B088: Health insurance status, stage at presentation and survival among female patients with head and neck cancer.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
B088-B088.
2020
-
Abstract C007: Racial differences in feasibility and perceived value of electronic symptom monitoring in a cohort of Black and White bladder and prostate cancer patients.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
C007-C007.
2020
-
Abstract C038: First- and second-degree family history of ovarian and breast cancers in relation to risk of invasive ovarian cancer in African American and White women.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
C038-C038.
2020
-
Abstract C044: Dietary inflammatory potential prior to diagnosis and risk of all-cause mortality among African-American women with ovarian carcinoma.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
C044-C044.
2020
-
Abstract C070: Racial disparities in body mass index and ovarian cancer risk in the OCWAA Consortium.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
C070-C070.
2020
-
Abstract D010: Developing an inflammatory breast cancer campaign: Results from focus groups led by Komen scholars.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
D010-D010.
2020
-
Abstract D064: Race-related RNA splicing dysregulation of PI3Kd signaling: A therapeutic target for aggressive prostate cancer.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
D064-D064.
2020
-
Abstract D071: Impact of racial differences in financial burden on time to treatment.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
D071-D071.
2020
-
Abstract D084: Overall survival (OS) of African-American (AA) and Caucasian (CAU) men who received sipuleucel-T for metastatic castration-resistant prostate cancer (mCRPC)—final PROCEED analysis.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
D084-D084.
2020
-
Abstract D093: Who carries the excess cancer risk burden: Implications of disparities in polycyclic aromatic hydrocarbon exposure.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
D093-D093.
2020
-
Abstract IA18: North Carolina Central University and Duke Cancer Institute's collaborative cancer research and education program: Connecting cancer disparities translational research, clinical trials operations, and community engagement.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
IA18-IA18.
2020
-
Abstract PR11: Racial differences in characteristics of early- vs. late-onset colorectal cancer among veterans.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
PR11-PR11.
2020
-
Auto-antibodies to p53 and the Subsequent Development of Colorectal Cancer in a United States Prospective Cohort Consortium.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
690-690.
2020
-
Abstract GS2-05: Microscaled proteogenomic methods for precision oncology.
Cancer Research.
2020
-
Abstract OT1-05-01: The incidence of febrile neutropenia (FN) for chemotherapy patients receiving pegfilgrastim by an on-body injector (pegfilgrastim OBI) versus other FN prophylaxis strategies.
Cancer Research.
2020
-
Abstract P1-03-03: Multichannel serial imaging of transgenic, preclinical murine models provides the first quantitative analysis of the unusual growth kinetics and lymph-vascular invasion of patient-derived inflammatory breast cancer cells and tumor emboli.
Cancer Research.
2020
-
Abstract P1-06-02: Characterization of gene- and sample-level APOBEC mutagenesis enrichment with respect to intrinsic subtypes, tumor mutational burden, and immune composition in breast cancer.
Cancer Research.
2020
-
Abstract P1-19-03: JAVELIN PARP Medley, a phase 1b/2 study of avelumab plus talazoparib: Results from advanced breast cancer cohorts.
Cancer Research.
2020
-
Abstract P1-21-07: The Patient-reported Outcomes after Routine Treatment of Atypical Lesions (PORTAL) study: Pain, psychosocial wellbeing, and quality of life among women undergoing guideline concordant care for DCIS vs. active surveillance for in situ and atypical lesions.
Cancer Research.
2020
-
Abstract P2-10-18: Deciphering racial disparities in breast cancer collagen reorganization by targeted extracellular matrix proteomics.
Cancer Research.
2020
-
Abstract P3-06-09: Incidence of ROS1 genomic alterations in breast cancer.
Cancer Research.
2020
-
Abstract P3-08-10: Characterization of oncotype DX recurrence score and chemotherapy utilization patterns in young women (≤40) with early stage ER+/HER-, lymph node negative breast cancer.
Cancer Research.
2020
-
Abstract P4-05-03: Mutational analysis of triple-negative breast cancer (TNBC): CALGB 40603 (Alliance).
Cancer Research.
2020
-
Abstract P4-12-10: Clinical implementation of the machine learning-based automated treatment planning tool for whole breast radiotherapy.
Cancer Research.
2020
-
Abstract P5-14-07: Avoidable acute care involving chemotherapy-induced nausea and vomiting (CINV) among patients with breast cancer receiving anthracycline + cyclophosphamide (AC) with NEPA prophylaxis relative to other antiemetics: An external control arm analysis.
Cancer Research.
2020
-
Abstract P5-14-11: Cardiac monitoring in advanced breast cancer patients treated with trastuzumab: Does it improve cardiac safety?.
Cancer Research.
2020
-
Abstract P5-14-17: Musculoskeletal side effects over time and association with adherence in women taking neoadjuvant letrozole for estrogen receptor positive DCIS: CALGB 40903 (Alliance).
Cancer Research.
2020
-
Abstract P5-14-18: Cardioprotective therapy in breast cancer patients with subclinical and clinical cardiotoxicty.
Cancer Research.
2020
-
Abstract PD10-10: Factors associated with decreased relative dose intensity in older adults with early-stage breast cancer receiving chemotherapy.
Cancer Research.
2020
-
Abstract A074: Correlation of homologous recombination deficiency (HRD) status by BROCA-HR sequencing with response to combination cediranib and olaparib in relapsed ovarian cancer.
Molecular Cancer Therapeutics.
A074-A074.
2019
-
Abstract 1149: Systems pathology by Optra 30 color multiplex immunofluorescence automated whole slide imaging system integrated with image analysis.
Cancer Research.
1149-1149.
2019
-
Abstract 1675: Analytical validation of MSI High detection with GuardantOMNI.
Cancer Research.
1675-1675.
2019
-
Abstract 2745: Tumor microenvironment and host genetics impact glioma progression in a Collaborative Cross-based orthotopic allograft model.
Cancer Research.
2745-2745.
2019
-
Abstract 3590: Mechanisms and inhibition RIOK2 for obesity-driven prostate cancer.
Cancer Research.
3590-3590.
2019
-
Abstract 3670: Transcriptional co-activators TAZ/YAP are novel regulators of PAX3-FOXO1 transcriptional programing and fusion-positive rhabdomyosarcoma cancer cell stemness.
Cancer Research.
3670-3670.
2019
-
Abstract 3731: A novel heat shock protein 90-targeted photosensitizer (HS-201) enables enhanced tumor-specific photodynamic therapy of inflammatory breast cancers.
Cancer Research.
3731-3731.
2019
-
Abstract 4071: A novel combination therapy of high intensity focused ultrasound and PDL1 blockades against advanced breast cancer.
Cancer Research.
4071-4071.
2019
-
Abstract 4173: Previously identified common glioma risk SNPs are associated with familial glioma.
Cancer Research.
4173-4173.
2019
-
Abstract 4215: Patient and screening characteristics associated with positive lung cancer screening examinations.
Cancer Research.
4215-4215.
2019
-
Abstract 4515: Utilizing nucleic-acid scavengers (NASs) to inhibit proinflammatory and proinvasive signaling in triple-negative breast cancer.
Cancer Research.
4515-4515.
2019
-
Abstract 750: Ancestry-related differentially spliced and expressed genes in prostate cancer.
Cancer Research.
750-750.
2019
-
Abstract 862: Inhibition of Hippo tumor suppressors MST1/2 slows prostate cancer cell proliferation and invasion.
Cancer Research.
862-862.
2019
-
Abstract CT135: Cetuximab (C) in patients (Pts) with breast cancer (BC) and non-small cell lung cancer (NSCLC) without reported KRAS, NRAS, BRAF
mutations: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.
Cancer Research.
CT135-CT135.
2019
-
Abstract CT146: Sunitinib (S) in patients (Pts) with metastatic colorectal cancer (mCRC) with FLT-3
alterations: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.
Cancer Research.
CT146-CT146.
2019
-
Abstract CT162: Pembrolizumab monotherapy for the adjuvant treatment of renal cell carcinoma post-nephrectomy: Randomized, double-blind, Phase III KEYNOTE-564 study.
Cancer Research.
CT162-CT162.
2019
-
Abstract CT220: Expansion into multiple institutions for training in the use of the LUM Imaging System for intraoperative detection of residual cancer in the tumor bed of female subjects with breast cancer.
Cancer Research.
CT220-CT220.
2019
-
Abstract LB-103: Defining oncogenic SWI/SNF complex mediated immune reprogramming in squamous cell carcinoma.
Cancer Research.
2019
-
Abstract LB-235: COLOMATE: Colorectal cancer and liquid biopsy screening protocol for molecularly assigned therapy.
Cancer Research.
2019
-
Abstract LB-287: Combination therapies with CDK4/6 inhibitors to treat KRAS-
mutant pancreatic cancer.
Cancer Research.
2019
-
Abstract ES10-3: Blockade of estrogen signaling boosts antitumor immunity by inhibiting tumor-induced pathological myelopoiesis.
Cancer Research.
2019
-
Abstract P1-06-04: Small-molecule screening nominates diverse combination therapies that sensitize BRCA mutant and wild-type triple negative breast cancer to PARP inhibition.
Cancer Research.
2019
-
Abstract P2-09-16: CD8 T cells induced by novel alphaviral vector predict improved progression free survival in advanced HER2+ breast cancer patients.
Cancer Research.
2019
-
Abstract P3-06-12: Genetic heterogeneity of DCIS is a predictor of invasive cancer.
Cancer Research.
2019
-
Abstract P3-08-07: Distinct biological signatures describe differences in BRCA mutated subgroups.
Cancer Research.
2019
-
Abstract P4-09-08: Shared-patient physician networks and their impact on the uptake of genomic testing in early-stage breast cancer.
Cancer Research.
2019
-
Abstract P4-16-05: Avoidable acute care use associated with nausea and emesis among patients receiving AC, carboplatin, or cisplatin for breast cancer.
Cancer Research.
2019
-
Abstract P4-16-09: Effect of simvastatin on cardiac strain in breast cancer patients receiving anthracycline therapy.
Cancer Research.
2019
-
Abstract PD6-08: Medicare costs for women after breast cancer: Preparing for survivorship.
Cancer Research.
2019
-
Abstract A47: Inhibition of histone methyltransferase with novel epipolythiodioxopiperazines (ETP) alkaloids in pediatric high-grade glioma.
Cancer Research.
A47-A47.
2018
-
Abstract A22: Augmentation of a novel adenoviral vaccine strategy by checkpoint inhibitors.
Cancer Immunology Research.
A22-A22.
2018
-
Abstract A79: Cancer immunotherapy with recombinant poliovirus induces IFN-dominant activation of antigen-presenting cells and tumor antigen-specific CTLs.
Cancer Immunology Research.
A79-A79.
2018
-
Abstract B66: Targeted activation of innate immune adaptors MAVS and STING promotes antitumor responses in colorectal cancer models.
Cancer Immunology Research.
B66-B66.
2018
-
Abstract A031: Androgen deprivation therapy-induced TGFBI signaling promotes EMT and bone metastasis of prostate cancer.
Cancer Research.
A031-A031.
2018
-
Abstract B038: Convergent hormone therapy resistance mediated by stress/dormancy-like pathways in prostate cancer.
Cancer Research.
B038-B038.
2018
-
Abstract 1695: A multi-institutional study to evaluate automated scoring of immunohistochemistry slides for assessment of programmed death-ligand 1 (PD-L1) expression in non-small cell lung cancer.
Cancer Research.
1695-1695.
2018
-
Abstract 1805: Development of a selective androgen receptor degrader (SARD) for treatment of castration-resistant prostate cancer.
Cancer Research.
1805-1805.
2018
-
Abstract 2255: Using tumor sample gene expression data to infer tumor purity levels with stochastic gradient boosting machines.
Cancer Research.
2255-2255.
2018
-
Abstract 233: Evaluating glioma risk associated with extent of European admixture in African-Americans and Latinos.
Cancer Research.
233-233.
2018
-
Abstract 2813: Efficacy and pharmacokinetics of niraparib in BRCA
-mutant and wild-type intracranial triple negative breast cancer murine models.
Cancer Research.
2813-2813.
2018
-
Abstract 3229: Prediagnostic biomarkers of metabolic dysregulation and cancer mortality.
Cancer Research.
3229-3229.
2018
-
Abstract 388: p16/MTAP status as a model for investigating gene-environment interactions in metabolism.
Cancer Research.
388-388.
2018
-
Abstract 4152: Synergistic gold nanostar-mediated photothermal and immunotherapy for cancer metastasis treatment.
Cancer Research.
4152-4152.
2018
-
Abstract 4220: Heterogeneous distribution of prognostic protein markers in glioblastoma.
Cancer Research.
4220-4220.
2018
-
Abstract 4854: Targeting ribonucleotide reductase M2 using didox causes inhibition of estrogen receptor-negative, inflammatory breast cancer cell proliferation and tumor emboli formation in culture.
Cancer Research.
4854-4854.
2018
-
Abstract 5256: A prospective study of inflammatory diet potential and risk of hepatocellular carcinoma (HCC).
Cancer Research.
5256-5256.
2018
-
Abstract 5318: High-grade serous ovarian cancer DNA methylation and survival in African-American women.
Cancer Research.
5318-5318.
2018
-
Abstract 5474: Activity of the S1P pathway promotes ovarian cancer and serves as a novel metabolic target of metformin.
Cancer Research.
5474-5474.
2018
-
Abstract 5496: A predictive model for selective targeting of the Warburg effect through GAPDH inhibition with a natural product.
Cancer Research.
5496-5496.
2018
-
Abstract 5497: Effective combination therapy for breast cancer targeting BACH1 and mitochondrial metabolism.
Cancer Research.
5497-5497.
2018
-
Abstract 5551: SGN-2FF: A small-molecule inhibitor of fucosylation modulates immune cell activity in preclinical models and demonstrates pharmacodynamic activity in early phase 1 analysis.
Cancer Research.
5551-5551.
2018
-
Abstract 5702: Characterization of circulating tumor cells during immune checkpoint inhibition in metastatic renal cell carcinoma and malignant melanoma.
Cancer Research.
5702-5702.
2018
-
Abstract LB-302: Oncolytic poliovirus-mediated inflammation and immunity in breast cancer.
Cancer Research.
2018
-
Abstract SY01-02: Blockade of estrogen signaling boosts antitumor immunity by dwindling cancer-promoting myelopoiesis.
Cancer Research.
2018
-
Abstract PR09: Clonal dynamics during breast cancer dormancy and recurrence.
Cancer Research.
PR09-PR09.
2018
-
Abstract B166: Investigating the effect of CDK4/6 and MDM2 inhibition on melanoma.
Molecular Cancer Therapeutics.
B166-B166.
2018
-
Abstract CN02-02: Immunotherapy for central nervous system cancers.
Molecular Cancer Therapeutics.
2018
-
Abstract A03: Several rational combination kinase inhibitor treatments identified by synthetic lethality screens are efficacious in intracranial triple negative breast cancer models.
Molecular Cancer Therapeutics.
A03-A03.
2017
-
Abstract PR18: Leveraging synthetic lethality to target convergent therapeutic resistance.
Molecular Cancer Therapeutics.
PR18-PR18.
2017
-
Abstract 1172: In vivo
pharmacokinetic properties and antitumor efficacy of porcupine lead inhibitors in the orthotopic murine MMTV-Wnt1 breast tumor model and the human HPAF-II pancreatic xenograft mouse model.
Cancer Research.
1172-1172.
2017
-
Abstract 1289: Evaluation of vitamin D receptor regulated genes reveals EGFR polymorphism is associated with high-grade serous ovarian cancer in African American women.
Cancer Research.
1289-1289.
2017
-
Abstract 1302: Genome-wide association study of glioma reveals specific differences in genetic susceptibility to glioblastoma and non-glioblastoma.
Cancer Research.
1302-1302.
2017
-
Abstract 1315: Estimating sex-specific effects of genetic loci associated with glioma risk.
Cancer Research.
1315-1315.
2017
-
Abstract 1859: Hsp90 targeted near infrared molecular imaging to detect mammografically occult invasive lobular breast cancer.
Cancer Research.
1859-1859.
2017
-
Abstract 1991: Enhanced role of the extracellular matrix in ovarian cancer recurrence.
Cancer Research.
1991-1991.
2017
-
Abstract 2272: A prospective study of urinary prostaglandin E2 metabolite, Helicobacter pylori
antibodies, and gastric cancer risk.
Cancer Research.
2272-2272.
2017
-
Abstract 268: Tracking HPV vaccination of young boys: is parental recall as dependable as physician records.
Cancer Research.
268-268.
2017
-
Abstract 2796: Development of a RAD51-based assay for determining homologous recombination proficiency and PARP inhibitor sensitivity.
Cancer Research.
2796-2796.
2017
-
Abstract 2810: Using CRISPR/Cas9 to generate primary soft tissue sarcoma in genetically engineered and wild-type mice.
Cancer Research.
2810-2810.
2017
-
Abstract 3187: Role of exosome secretion in the survival of enzalutamide-resistant prostate cancer cells: Syntaxin 6 as a novel therapeutic target.
Cancer Research.
3187-3187.
2017
-
Abstract 3707: Tumor-associated neutrophils with antigen-presenting features in early-stage human lung cancer.
Cancer Research.
3707-3707.
2017
-
Abstract 4221: Factors associated with HPV vaccination initiation and completion among 18-26 year olds in the United States.
Cancer Research.
4221-4221.
2017
-
Abstract 4243: Epigenome-wide association study of metabolic syndrome in African-Americans.
Cancer Research.
4243-4243.
2017
-
Abstract 4709: Induction of enhanced tumor-specific immunity by Hsp90 targeted photodynamic therapy (Hsp90-PDT) combined with immune checkpoint inhibition.
Cancer Research.
4709-4709.
2017
-
Abstract 5830: A novel Notch-YAP circuit drives stemness and tumorigenesis in embryonal rhabdomyosarcoma.
Cancer Research.
5830-5830.
2017
-
Abstract 588: Advanced molecular characterization of severe autoimmune toxicities associated with checkpoint inhibitor therapies.
Cancer Research.
588-588.
2017
-
Abstract 666: CD37 tetraspanin as a novel biomarker for PD-1 blockade in diffuse large B-cell lymphoma.
Cancer Research.
666-666.
2017
-
Abstract CT047: Phase 1 dose-escalation study of the CDK inhibitor dinaciclib in combination with the PARP inhibitor veliparib in patients with advanced solid tumors.
Cancer Research.
CT047-CT047.
2017
-
Abstract IA17: Non-canonical aspects of ATM and p53 signaling pathways.
Molecular Cancer Research : Mcr.
IA17-IA17.
2017
-
Abstract A38: Checkpoint blockade elicits unique T cell expansion to promote tumor regression.
Cancer Immunology Research.
A38-A38.
2017
-
Abstract B04: Intralesional vaccination with Ad-MAVS alters the immunosuppressive tumor microenvironment and elicits robust anti-tumor immunity in non-immunogenic cancers.
Cancer Immunology Research.
B04-B04.
2017
-
Abstract B36: Modulating the tumor microenvironment to enhance cancer immunotherapy by inducing phosphatidylserine expression on the tumor surface.
Cancer Immunology Research.
B36-B36.
2017
-
Abstract OT1-04-06: NRG-BR002: A phase IIR/III trial of standard of care therapy with or without stereotactic body radiotherapy (SBRT) &/or surgical ablation for newly oligometastatic breast cancer.
Cancer Research.
2017
-
Abstract P1-01-01: Circulating tumor cell number and CTC-endocrine therapy index predict clinical outcomes in ER positive metastatic breast cancer patients: Results of the COMETI Phase 2 trial.
Cancer Research.
2017
-
Abstract P1-05-30: Genomic and microenvironmental intra-tumor heterogeneity in DCIS.
Cancer Research.
2017
-
Abstract P1-06-06: Evidence for tumor heterogeneity and clonal evolution during invasive progression of breast cancer.
Cancer Research.
2017
-
Abstract P2-04-19: Elucidating the tumor immune microenvironment phenotype in early stage untreated BRCA mutated breast cancer patients.
Cancer Research.
2017
-
Abstract P2-04-27: CTLA-4 and PD-1 checkpoint inhibitors enhance individually tailored adaptive anti-tumor immune responses to overcome tumor immunosuppression and effectively treat triple-negative breast cancer.
Cancer Research.
2017
-
Abstract P3-07-14: Targeting ERR-α regulated lactate metabolism eliminates drug-resistant breast cancer cells.
Cancer Research.
2017
-
Abstract P3-16-02: Nanotheranostics using plasmonic gold nanostars to target inflammatory breast cancer cells and tumor emboli.
Cancer Research.
2017
-
Abstract P4-19-01: Non-metastatic and metastatic breast cancer patients' priorities when considering a treatment decision.
Cancer Research.
2017
-
Abstract P4-22-02: Evaluation of veliparib (V) and temozolomide (TMZ) in a phase 2 randomized study of the efficacy and tolerability of V+TMZ or carboplatin (C) and paclitaxel (P) vs placebo (Plc)+C/P in patients (pts) with BRCA1
or BRCA2
mutations and metastatic breast cancer.
Cancer Research.
2017
-
Abstract P5-08-12: HER2 status remains the primary predictor of improved survival in patients with BCBM over the past 2 decades (1996-2015).
Cancer Research.
2017
-
Abstract PD1-03: Multivariate analysis of subtype and gene expression signatures predictive of pathologic complete response (pCR) in triple-negative breast cancer (TNBC): CALGB 40603 (Alliance).
Cancer Research.
2017
-
Abstract S2-05: Efficacy and tolerability of veliparib (V; ABT-888) in combination with carboplatin (C) and paclitaxel (P) vs placebo (Plc)+C/P in patients (pts) with BRCA1
or BRCA2
mutations and metastatic breast cancer: A randomized, phase 2 study.
Cancer Research.
2017
-
Abstract S3-05: Integrated analysis of multidimensional genomic data on CALGB 40601 (Alliance), a randomized neoadjuvant phase III trial of weekly paclitaxel (T) and trastuzumab (H) with or without lapatinib (L) for HER2-positive breast cancer.
Cancer Research.
2017
-
Abstract A16: Smad4 pathways modulate induction of the chemokine Ccl20 and repress inflammation-induced carcinogenesis in mouse colon.
Cancer Research.
A16-A16.
2017
-
Abstract B44: Immune pathway dysregulations in inflammatory breast cancer health disparity.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
B44-B44.
2017
-
Abstract B51: Dairy, calcium, vitamin D and ovarian cancer risk in African-American women.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
B51-B51.
2017
-
Abstract B58: Single-nucleotide polymorphisms of race-related alternatively spliced genes associate with prostate cancer risk, aggressiveness and/or survival.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
B58-B58.
2017
-
Abstract B78: The interplay between smoking at diagnosis, marital status, and head and neck cancer survivorship.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
B78-B78.
2017
-
Abstract B79: Disparities in HPV vaccine initiation and completion based on sexual orientation among women in the United States.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
B79-B79.
2017
-
Abstract A032: Using oncolytic polio expressing tumor as a cancer vaccine.
Cancer Immunology Research.
A032-A032.
2016
-
Abstract A02: The origin and role of APC-like hybrid tumor-associated neutrophils in early-stage human lung cancer.
Cancer Research.
A02-A02.
2016
-
Abstract 1182: Heparin-binding epidermal growth factor-like growth factor is a pro-differentiating factor in neuroblastoma.
Cancer Research.
1182-1182.
2016
-
Abstract 129: Integrated genomic analysis of survival outliers in glioblastoma.
Cancer Research.
129-129.
2016
-
Abstract 1430: Do race and gender independently predict risk factors associated with the Human papillomavirus.
Cancer Research.
1430-1430.
2016
-
Abstract 1647: Radiation response genome-wide analysis using paired pre and post-radiation FFPE human breast tumor samples.
Cancer Research.
1647-1647.
2016
-
Abstract 1656: Subtype-specific radiation response in human breast cancer and potential therapeutic effect of FAS death receptor modulation.
Cancer Research.
1656-1656.
2016
-
Abstract 1735: Fruit and vegetable consumption and risk of gastric cancer: a prospective nested case-control study in China, Japan and Korea.
Cancer Research.
1735-1735.
2016
-
Abstract 1754: Body powder use and ovarian cancer: the African American Cancer Epidemiology Study.
Cancer Research.
1754-1754.
2016
-
Abstract 1771: Metabolic dysregulation and cancer mortality in a national cohort of African-Americans and whites.
Cancer Research.
1771-1771.
2016
-
Abstract 1785: Sociodemographic correlates of knowledge and risk perception of HPV and HPV-associated oropharyngeal cancer.
Cancer Research.
1785-1785.
2016
-
Abstract 1787: Adolescent boys and the human papillomavirus (HPV) - Geographical patterns of vaccination uptake.
Cancer Research.
1787-1787.
2016
-
Abstract 1852: Multiple PI3K pathway mutations predominate in low stage endometrial carcinomas.
Cancer Research.
1852-1852.
2016
-
Abstract 2037: A discovery study to identify clinical and genetic risk factors for bevacizumab (BEV)-related gastrointestinal (GI) hemorrhage (HEM) in metastatic castration-resistant prostate cancer (mCRPC) patients (pts) treated on CALGB 90401 (Alliance).
Cancer Research.
2037-2037.
2016
-
Abstract 2393: Kidneys of VHL patients reveal the origin of renal clear cell carcinoma.
Cancer Research.
2393-2393.
2016
-
Abstract 2577: A comparison of parent and provider verified HPV vaccination initiation and completion in US adolescents: findings from the National Immunization Survey - Teen, 2014.
Cancer Research.
2577-2577.
2016
-
Abstract 2691: Genome-wide association study identifies two susceptibility loci that modify radiation-related risk for breast cancer after childhood cancer: A report from the Childhood Cancer Survivor Study and St. Jude Lifetime Cohort.
Cancer Research.
2691-2691.
2016
-
Abstract 3388: Genetic prediction of VEGF-A plasma levels in cancer patients.
Cancer Research.
3388-3388.
2016
-
Abstract 3407: Gene expression subtypes of high grade serous ovarian cancer in African American women.
Cancer Research.
3407-3407.
2016
-
Abstract 3417: Peripheral CD8+CD28-suppressive T lymphocytes act as a prognosticator among breast cancer patients with adoptive T-cell immunotherapy.
Cancer Research.
3417-3417.
2016
-
Abstract 3472: Does being married independently predict survival in patients with head and neck cancer? Results from a single institution.
Cancer Research.
3472-3472.
2016
-
Abstract 3867: Combined PI3K and AURKA inhibition are efficacious in triple-negative breast cancer models.
Cancer Research.
3867-3867.
2016
-
Abstract 797: A splicing variant of TERT identified by GWAS interacts with menopausal estrogen therapy in risk of ovarian cancer.
Cancer Research.
797-797.
2016
-
Abstract LB-015: XIAP induction by the MAPK-eIF4G1 pathway drives NFκB activation in inflammatory breast cancer growth and therapeutic resistance.
Cancer Research.
2016
-
Abstract LB-361: Serology of Streptococcus gallolyticus subsp. gallolyticus and risk of colorectal cancer.
Cancer Research.
2016
-
Abstract SY22-02: Exercise and cancer progression: Preclinical evidence.
Cancer Research.
2016
-
Abstract A51: Racial and gender disparities in knowledge and awareness of HPV and HPV vaccine in a national sample of U.S. adults.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
A51-A51.
2016
-
Abstract A52: Sociodemographic predictors of HPV and HPV vaccine knowledge and awareness among Americans who use the Internet as their primary source of health information.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
A52-A52.
2016
-
Abstract A60: A paradox: Engaging in at-risk behavior may not correlate with perceived susceptibility to cancer or heart disease.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
A60-A60.
2016
-
Abstract A73: Obesity, weight gain, and ovarian cancer risk in African American women.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
A73-A73.
2016
-
Abstract B18: Development of novel therapeutic splice-switching oligonucleotides against aggressive prostate cancer in men of African descent.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
B18-B18.
2016
-
Abstract B40: Rare variant discovery in known cancer genes from whole-exome sequencingof African American hereditary prostate cancer families.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
B40-B40.
2016
-
Abstract B58: Assessing university students' sexual risk behavior, knowledge of the human papillomavirus, (HPV), HPV vaccine, and association between HPV and head and neck cancer.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
B58-B58.
2016
-
Abstract B70: Characteristics, risk perception, and predictors of oral cancer knowledge among drag racers and their fans.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
B70-B70.
2016
-
Abstract B89: HPV is not just a woman's business! Understanding the gaps in men's knowledge of HPV and HPV vaccine.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
B89-B89.
2016
-
Abstract C47: Gender and racial disparities in long-term survival of oral and oropharyngeal cancer in the United States.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
C47-C47.
2016
-
Abstract IA09: Intervening on the financial toxicity of cancer care.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
IA09-IA09.
2016
-
Abstract PR05: Dietary quality and ovarian cancer risk in African American women.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
PR05-PR05.
2016
-
Abstract ES8-3: Endocrine management of premalignant lesions and DCIS.
Cancer Research.
2016
-
Abstract OT3-03-04: NRG-BR002: A phase IIR/III trial of standard of care therapy with or without stereotactic body radiotherapy (SBRT) &/or surgical ablation for newly oligometastatic breast cancer.
Cancer Research.
2016
-
Abstract P3-14-04: Effects of the dual selective CYP17 lyase inhibitor and androgen receptor (AR) antagonist, VT-464, on AR+ and ER+ tumor models in vitro and in vivo.
Cancer Research.
2016
-
Abstract P4-08-03: DEAD-box RNA helicase DP103 as a novel regulator of Wnt/β-catenin signaling pathway and promotes cancer stem cell-like behavior in triple negative breast cancers.
Cancer Research.
2016
-
Abstract P4-09-16: A monoclonal antibody with exceptional specificity across major breast cancer subtypes.
Cancer Research.
2016
-
Abstract P4-13-25: Abemaciclib, an inhibitor of CDK4 and CDK6, combined with endocrine and HER2-targeted therapies for women with metastatic breast cancer.
Cancer Research.
2016
-
Abstract P4-14-16: T-cell clonality increases after neoadjuvant treatment with trastuzumab and pertuzumab.
Cancer Research.
2016
-
Abstract P5-17-03: The 12-gene DCIS score assay: Impact on radiation treatment (XRT) recommendations and clinical utility.
Cancer Research.
2016
-
Abstract P6-04-11: The foundation one assay influences clinical decision making in metastatic breast cancer.
Cancer Research.
2016
-
Abstract P6-05-03: Genomic diversity of ductal carcinoma in situ (DCIS) as a driver of invasion and metastasis.
Cancer Research.
2016
-
Abstract S3-06: Treatment outcomes in patients with invasive breast cancer treated with neoadjuvant systemic therapy and breast MR imaging: Results of a secondary analysis of TBCRC 017.
Cancer Research.
2016
-
Abstract A30: Frizzled-7 (FZD7)-mediated non-canonical Wnt-Planar Cell Polarity (PCP) signalling pathway as a novel molecular driver for the C5/Proliferative/Stem-A molecular subtype of ovarian cancer..
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research.
A30-A30.
2016
-
Abstract B63: Expression of VEGF in ovarian cancer suppresses tumor immunity through recruitment of myeloid derived suppressor cells..
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research.
B63-B63.
2016
-
Abstract IA32: Commensal microorganisms and polymorphic mucosal surfaces determine the evolution of distal metastatic tumors.
Cancer Immunology Research.
IA32-IA32.
2016
-
Abstract A12: Genomically unstable glioblastoma are sensitive to Parp inhibition.
Cancer Research.
A12-A12.
2015
-
Abstract A24: The dual PI3K δ/γ inhibitor, RP6530, in combination with ibrutinib or fludarabine, synergistically enhances cytotoxicity in primary CLL cells in vitro..
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research.
A24-A24.
2015
-
Abstract POSTER-BIOL-1319: Temporal shifts in the epigenetic regulation of tight junctions from primary to recurrent ovarian cancer.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research.
2015
-
Abstract POSTER-TECH-1123: Advancing metformin as therapeutic for ovarian cancer: metabolomic profiling of mouse ovarian tumors identifies metformin-induced global metabolic changes.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research.
2015
-
Abstract POSTER-THER-1420: Ascites drives ovarian cancer stem-like cell growth: therapeutic opportunities.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research.
2015
-
Abstract 1100: Functional genomics to investigate the genetic determinants of cell death induced by oxidative stresses.
Cancer Research.
1100-1100.
2015
-
Abstract 1585: Application of a graphene oxide based microfluidic device (GO Chip) to prostate cancer circulating tumor cell capture and analysis.
Cancer Research.
1585-1585.
2015
-
Abstract 1610: Development of meta-[211At]astatobenzylguanidine ([211At]MABG) as an alpha particle emitting systemic targeted radiotherapeutic for neuroblastoma.
Cancer Research.
1610-1610.
2015
-
Abstract 1809: Next-generation brachytherapy: a preclinical study of a thermally stabilized biopolymer gel for delivering intratumoral radionuclide therapy in a pancreatic tumor mouse model.
Cancer Research.
1809-1809.
2015
-
Abstract 1847: AR-V7 regulation during epithelial plasticity.
Cancer Research.
1847-1847.
2015
-
Abstract 2236: Emergence of epigenetic regulation of tight junction genes in recurrent serous epithelial ovarian cancer.
Cancer Research.
2236-2236.
2015
-
Abstract 2579: Combination therapy with MEK inhibition is efficacious in intracranial triple negative breast cancer models.
Cancer Research.
2579-2579.
2015
-
Abstract 2703: Overcoming Lapatinib resistance by the fatty acid synthase inhibitor HS-106.
Cancer Research.
2703-2703.
2015
-
Abstract 3004: Contextual RNAi screen identifies ACLY and ACC1 as mediators of hypoxia-induced apoptosis through metabolic and transcriptional mechanisms.
Cancer Research.
3004-3004.
2015
-
Abstract 3212: Metastatic breast cancer cell communication within a pro-dormancy bone marrow niche.
Cancer Research.
3212-3212.
2015
-
Abstract 3302: Subtype-specific radiation response in a mouse model of human breast cancer.
Cancer Research.
3302-3302.
2015
-
Abstract 3331: Gene expression profiling after radiation in human breast cancer specimens and breast cancer cell lines.
Cancer Research.
3331-3331.
2015
-
Abstract 3732: Detecting germline PTEN mutations among at-risk cancer patients: An age and gender-specific cost effectiveness analysis.
Cancer Research.
3732-3732.
2015
-
Abstract 3912: GDF2 promotes anoikis susceptibility in ovarian and breast epithelia.
Cancer Research.
3912-3912.
2015
-
Abstract 4449: A novel Porcupine inhibitor is effective in the treatment of cancers with RNF43 mutations.
Cancer Research.
4449-4449.
2015
-
Abstract 4633: Evidence that long non-coding RNA variants associate with epithelial ovarian cancer risk.
Cancer Research.
4633-4633.
2015
-
Abstract 4634: Variants within super-enhancer regulatory elements associate with epithelial ovarian cancer risk.
Cancer Research.
4634-4634.
2015
-
Abstract 4635: Inherited variants affecting RNA editing may contribute to ovarian cancer susceptibility.
Cancer Research.
4635-4635.
2015
-
Abstract 4636: Investigation of exome variants associated with overall survival in ovarian cancer.
Cancer Research.
4636-4636.
2015
-
Abstract 5465: Systematic interrogation of druggable pathways in pancreatic adenocarcinomas using pooled gene-knockdown lentiviral libraries.
Cancer Research.
5465-5465.
2015
-
Abstract 880: Obesity predicts prostate cancer-specific mortality after radical prostatectomy: Results from the SEARCH database.
Cancer Research.
880-880.
2015
-
Abstract 891: FGF21 prevents high fat diet-induced pancreatic cancer in mice expressing oncogenic Kras.
Cancer Research.
891-891.
2015
-
Abstract LB-087: A facilitative role for caspase 3 in promoting genetic instability and carcinogenesis.
Cancer Research.
2015
-
Abstract SY36-03: Intraoperative molecular imaging with protease-activated fluorescent imaging agents.
Cancer Research.
2015
-
Abstract B98: Final results of a randomized phase Ib study of fractionated 90Y-clivatuzumab tetraxetan in patients with metastatic pancreatic cancer having at least two prior therapies.
Cancer Research.
B98-B98.
2015
-
Abstract P1-10-02: Adjuvant radiation after lumpectomy: A cost comparison of treatment patterns in 43,247 women from the National Cancer Data Base.
Cancer Research.
2015
-
Abstract P1-10-04: Post-operative imaging after atypical ductal hyperplasia excision: The findings and costs.
Cancer Research.
2015
-
Abstract P1-15-10: Low utilization of hypofractionated radiotherapy for the treatment of early-stage breast cancer in the US.
Cancer Research.
2015
-
Abstract P2-12-07: The association between exercise behavior and patient-reported outcomes in women with early breast cancer receiving locoregional radiation therapy.
Cancer Research.
2015
-
Abstract P3-07-22: Predictors of neoadjuvant chemotherapy use in women with breast cancer: A review of 169,329 patients from the American College of Surgeons' National Cancer Database.
Cancer Research.
2015
-
Abstract P5-15-07: Association of patient preference for adjuvant chemotherapy (chemo) at baseline (BL) with toxicity, mental health, function, quality of life (QoL) and survival in older women with early stage breast cancer (ESBC) [CALGB 49907 Alliance].
Cancer Research.
2015
-
Abstract P6-07-06: Post-transcriptional coordination of gene expression during breast cancer tumorigenesis.
Cancer Research.
2015
-
Abstract P6-14-05: A novel link between anti-apoptotic signaling, NFκB, and SMAD7 in IBC pathobiology.
Cancer Research.
2015
-
Acculturation and Ethnic Variations in Breast Cancer Risk Factors, Gail Model Risk Estimates and Mammographic Breast Density.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
760-760.
2015
-
Abstract A41: Hypoxia-dependent modification of collagen networks promotes sarcoma metastasis.
Cancer Research.
A41-A41.
2015
-
Abstract PR09: A genome-wide RNAi screen reveals a protective role of decreased lipogenesis under hypoxia.
Cancer Research.
PR09-PR09.
2015
-
Abstract A23: Oncogenic Ras induces inflammatory cytokine production by upregulating squamous cell carcinoma antigen (SerpinB3).
Molecular Cancer Research : Mcr.
A23-A23.
2014
-
Abstract IA11: New insights into DNA double-strand break responses.
Cancer Research.
IA11-IA11.
2014
-
Abstract B05: MRI provides a more reliable method of esophageal tumor detection than endoscopy in a rat model.
Molecular Cancer Research : Mcr.
B05-B05.
2014
-
Abstract A64: A role for injury in sarcomagenesis.
Cancer Research.
A64-A64.
2014
-
Abstract 1265: Carbohydrate intake, glycemic index and prostate cancer risk.
Cancer Research.
1265-1265.
2014
-
Abstract 1904: RNA expression based screening of ALK gene fusion from formalin fixed non-small cell lung cancer samples.
Cancer Research.
1904-1904.
2014
-
Abstract 2320: Clinical epigenetic resensitization of platinum-resistant, recurrent ovarian cancer patients with SGI-110, a novel, second-generation, subcutaneously administered hypomethylating agent (HMA).
Cancer Research.
2320-2320.
2014
-
Abstract 2674: Stroma biology identifies heparins as differentiating agents in neuroblastoma.
Cancer Research.
2674-2674.
2014
-
Abstract 2970: Differential effects of caloric and carbohydrate restriction on prostate cancer in a mouse model.
Cancer Research.
2970-2970.
2014
-
Abstract 3283: GWAS identifies risk variants for mucinous ovarian carcinoma.
Cancer Research.
3283-3283.
2014
-
Abstract 3311: The cholesterol/ 27-hydroxycholesterol axis is a novel therapeutic target in castrate resistant prostate cancer.
Cancer Research.
3311-3311.
2014
-
Abstract 3536: Roles of miR-215 and regulatory mechanisms for its biogenesis in response to hypoxia in glioblastoma stem cells.
Cancer Research.
3536-3536.
2014
-
Abstract 3774: Hyperthermia treatment overcomes temozolomide resistance in glioma cells by downregulating MGMT
expression and increasing temozolomide uptake.
Cancer Research.
3774-3774.
2014
-
Abstract 3777: Combining VELIPARIB (ABT-888) with temozolomide shows strong synergy when treating temozolomide-resistant and recurrent GBM cell lines.
Cancer Research.
3777-3777.
2014
-
Abstract 3841: Bevacizumab (BEV) and risk of arterial (ATE) and venous thromboembolism (VTE) in metastatic castration-resistant prostate cancer (mCRPC) patients treated on CALGB 90401(ALLIANCE).
Cancer Research.
3841-3841.
2014
-
Abstract 4117: Utilizing RNA aptamers for biomarker discovery in a novel cell culture system for hepatocellular carcinoma.
Cancer Research.
4117-4117.
2014
-
Abstract 4137: Latent class model characterization of neighborhood SES.
Cancer Research.
4137-4137.
2014
-
Abstract 4270: The use of mutational signatures in identifying carcinogen exposure.
Cancer Research.
4270-4270.
2014
-
Abstract 4481: Genetically encoded chimeric polypeptide nanoparticles for gemcitabine delivery to solid tumors.
Cancer Research.
4481-4481.
2014
-
Abstract 4518: The PI3K-δ inhibitor TGR-1202 induces cytotoxicity and inhibits phosphorylation of AKT in 17p deleted and non-17p deleted CLL cells in vitro.
Cancer Research.
4518-4518.
2014
-
Abstract 4570: Role of ERRalpha in ovarian cancer.
Cancer Research.
4570-4570.
2014
-
Abstract 4583: In situ photocontrolled intratumoral depot for combined photodynamic therapy and brachytherapy for solid tumor.
Cancer Research.
4583-4583.
2014
-
Abstract 4831: Breast cancer cells metastasize to bone through E-selectin+ vascular gateways.
Cancer Research.
4831-4831.
2014
-
Abstract 5168: Gastric adenocarcinomas show pervasive loss of heterozygosity and enrichment for “STOP” genes in regions of hemizygous deletion.
Cancer Research.
5168-5168.
2014
-
Abstract 518: Identification of differentially expressed microRNAs in human hepatocellular adenoma associated with type I glycogen storage disease: a potential utility as biomarkers.
Cancer Research.
518-518.
2014
-
Abstract 5447: Targeting vascular endothelial growth factor A and tumor hypoxia combined with radiation eradicates sarcomas through destruction of tumor vasculature and thwarting of the hypoxic response.
Cancer Research.
5447-5447.
2014
-
Abstract 5449A: PI3K and MEK inhibition in intracranial triple negative breast cancer: Efficacy of BKM120 and AZD6244 in preclinical mouse models.
Cancer Research.
5449A-5449A.
2014
-
Abstract 63: Driving brain tumorigenesis: Generation of a mutant IDH1 mouse model of progressive glioma.
Cancer Research.
63-63.
2014
-
Abstract 946: Exome genotyping array identifies rare and low-frequency variants that may be associated with ovarian cancer risk.
Cancer Research.
946-946.
2014
-
Abstract CT238: Phase III randomized, placebo controlled trial of COX-2 inhibition in addition to standard chemotherapy for advanced non-small cell lung cancer (NSCLC):CALGB 30801 (Alliance).
Cancer Research.
CT238-CT238.
2014
-
Abstract LB-123: Novel function of STAT1 pathway as a modulator of tumor progression in serous papillary endometrial cancer.
Cancer Research.
2014
-
Abstract LB-167: Tumor cells, but not endothelial cells, mediate the eradication of primary cancers by radiation therapy.
Cancer Research.
2014
-
Abstract LB-292: Race-associated gene expression in tumors and breast cancer mortality disparities.
Cancer Research.
2014
-
Abstract LB-89: Germ-line and somatic SMARCA4 mutations characterize small cell carcinoma of the ovary, hypercalcemic type.
Cancer Research.
2014
-
Abstract P2-16-13: Phase I dose escalation clinical trial of the PI3K inhibitor BKM120 and capecitabine (C) in metastatic breast cancer (MBC).
Cancer Research.
2013
-
Abstract P3-08-05: Chemotherapy-related amenorrhea on adjuvant paclitaxel-trastuzumab (APT trial).
Cancer Research.
2013
-
Abstract P5-14-04: Preoperative single-fraction partial breast radiotherapy – Initial results from a novel phase I dose-escalation protocol with exploration of radiation response biomarkers.
Cancer Research.
2013
-
Abstract S1-04: A phase II study of adjuvant paclitaxel (T) and trastuzumab (H) (APT trial) for node-negative, HER2-positive breast cancer (BC).
Cancer Research.
2013
-
Abstract S4-03: Exome sequencing reveals clinically actionable mutations in the pathogenesis and metastasis of triple negative breast cancer.
Cancer Research.
2013
-
Abstract C263: mTOR inhibition specifically sensitizes colorectal cancers with KRAS or BRAF mutations to BCL-2/BCL-XL inhibition by suppressing MCL-1..
Molecular Cancer Therapeutics.
C263-C263.
2013
-
Abstract C86: Tethered Hsp90 inhibitors carrying optical or radioiodinated probes reveal selective internalization of ectopic Hsp90 in malignant breast tumor cells..
Molecular Cancer Therapeutics.
C86-C86.
2013
-
Abstract A48: Enhanced efficacy of cisplatin and 5-fluorouracil combination with AUY-922 in esophageal adenocarcinoma cells.
Cancer Research.
A48-A48.
2013
-
Abstract 1199: NSCLC KRAS G12C and G12V mutations drive different pathways and display specific drug sensitivity patterns..
Cancer Research.
1199-1199.
2013
-
Abstract 1200: Molecular subtypes of gastric cancer show systematic differences in response to PI3K inhibitors and fluorouracil..
Cancer Research.
1200-1200.
2013
-
Abstract 1352: Epithelial-mesenchymal transition (EMT) gene variants influence epithelial ovarian cancer risk in women of European, African and Asian ancestry..
Cancer Research.
1352-1352.
2013
-
Abstract 1367: Item response theory analysis of the patient satisfaction with cancer-related care: psychometric validation in a multicultural sample of 1,296 participants..
Cancer Research.
1367-1367.
2013
-
Abstract 1376: Exercise alters breast cancer phenotype through distinct reductions in host-derived proinflammatory growth factor ligands..
Cancer Research.
1376-1376.
2013
-
Abstract 2079: Antitumoral activity of INC280 against adult glioblastoma brain tumors xenografts..
Cancer Research.
2079-2079.
2013
-
Abstract 2564: Identification of a novel SPOP missense mutation from targeted next-generation sequencing of men with chromosome 17-q linkage..
Cancer Research.
2564-2564.
2013
-
Abstract 330A: Differential expression of angiogenic genes in invasive high grade serous ovarian carcinomas..
Cancer Research.
330A-330A.
2013
-
Abstract 352: Murine model of chordoma: Sonic Hedgehog promoter-driven Cre activation of Brachyury (T) expression induces spinal disk abnormalities and perinatal lethal developmental defects..
Cancer Research.
352-352.
2013
-
Abstract 3647: Dose-dependent alteration of CpG methylation in AHRR
and GFI1
in mononuclear cell DNA of smokers..
Cancer Research.
3647-3647.
2013
-
Abstract 364: Exercise slows tumor progression and normalizes tumor vasculature in murine models of breast cancer..
Cancer Research.
364-364.
2013
-
Abstract 3698: Inhibition of cholesterol uptake with ezetimibe reduces intra-tumoral testosterone levels and slows tumor growth in transgenic mouse models of prostate cancer..
Cancer Research.
3698-3698.
2013
-
Abstract 3914: In vivo
label-free examination of early-stage melanoma formation..
Cancer Research.
3914-3914.
2013
-
Abstract 4341: A novel injectable polymer liquid that self-assembles into radioactive “seeds” for brachytherapy..
Cancer Research.
4341-4341.
2013
-
Abstract 4479: Preclinical toxicology and pharmacology for BACPTDP, a camptothecin that targets hypoxic/acidic tumors..
Cancer Research.
4479-4479.
2013
-
Abstract 4509: Genetically encoded chimeric polypeptide nanoparticles for paclitaxel delivery to triple negative breast cancer..
Cancer Research.
4509-4509.
2013
-
Abstract 4598: Identification of driver genes in hepatocellular carcinoma by exome sequencing..
Cancer Research.
4598-4598.
2013
-
Abstract 4707: Validation of survival prognostic models for non-small-cell lung cancer instage- and age-specific groups..
Cancer Research.
4707-4707.
2013
-
Abstract 4767: Preclinical mouse model of recurrent epithelial ovarian cancer..
Cancer Research.
4767-4767.
2013
-
Abstract 4850: Variation in circadian rhythm genes influence epithelial ovarian cancer risk and invasiveness..
Cancer Research.
4850-4850.
2013
-
Abstract 5041: The type III TGF-beta receptor promotes FGF2-mediated neuronal differentiation in neuroblastoma..
Cancer Research.
5041-5041.
2013
-
Abstract 510: Activation of PP2A by SET antagonism destabilizes c-Myc and inhibits breast cancer growth..
Cancer Research.
510-510.
2013
-
Abstract 5298: Two distinctive single nucleotide polymorphisms determine liver metastases responses to docetaxel plus thiotepa for metastatic breast cancer patients..
Cancer Research.
5298-5298.
2013
-
Abstract 5354: Altered DNA methylation at imprinted insulin-like growth factor-2 (IGF2) resulting from heavy metal exposure in vitro
and in vivo
in infants from the newborn epigenetic study (NEST)..
Cancer Research.
5354-5354.
2013
-
Abstract 5521: Application of an automated capillary isoelectric-focusing immunoassay to study dynamic oncoprotein phosphorylation in non-small cell lung cancer and for evaluating drug response to targeted therapies..
Cancer Research.
5521-5521.
2013
-
Abstract 5552: Manganese porphyrins in combination with ascorbate act as pro-oxidants and mediate caspase-independent cancer cell death..
Cancer Research.
5552-5552.
2013
-
Abstract 5615: Evaluation of the antitumoral efficacy and toxicity of injectable, polymeric radionuclide seeds in a noninvasive preclinical prostate tumor model..
Cancer Research.
5615-5615.
2013
-
Abstract 5681: Modulation of Wnt/β-catenin signaling by niclosamide and related derivatives..
Cancer Research.
5681-5681.
2013
-
Abstract 951: Cross-resistance and re-sensitization to multiple drugs in an IBC model of lapatinib acquired resistance parallels redox adaptation..
Cancer Research.
951-951.
2013
-
Abstract LB-161: A phase I safety study of NPC-1C, a novel, therapeutic antibody to treat pancreas and colorectal cancers..
Cancer Research.
2013
-
Abstract LB-164: Treatment of advanced stage colorectal cancer with ETBX-011 immunotherapeutic..
Cancer Research.
2013
-
Abstract LB-296: FDG-PET avidity negatively impacts survival in pStage I NSCLC in the ACOSOG Z4031 trial..
Cancer Research.
2013
-
Predictors of Colorectal Cancer Surveillance among Radiation-treated Survivors of Childhood Cancer.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
478-478.
2013
-
Abstract P1-13-05: The association between timing in adjuvant chemotherapy administration and overall survival for women with breast cancer within the National Comprehensive Cancer Network (NCCN).
Cancer Research.
2012
-
Abstract P4-09-01: Retrospective evaluation of precision of gene-expression-based signatures of prognosis and tumor biology in replicate surgical biospecimens from patients with breast cancer.
Cancer Research.
2012
-
Abstract P6-08-05: Changes in Cognitive Function in Older Women With Breast Cancer Treated with Standard Chemotherapy and Capecitabine within CALGB 49907.
Cancer Research.
2012
-
Abstract B35: Altered DNA methylation at imprinted insulin-like growth factor-2 (IGF2) resulting from heavy metal exposure in vitro and in vivo in infants from the Newborn Epigenetic STudy (NEST)..
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.
B35-B35.
2012
-
Abstract 1027: Helicobacter pylori blood biomarkers for gastric cancer risk in the Shanghai Men's Health Study.
Cancer Research.
1027-1027.
2012
-
Abstract 1058: Mutations in isocitrate dehydrogenase 1 and 2 are associated with DNA hypermethylation in intrahepatic cholangiocarcinomas.
Cancer Research.
1058-1058.
2012
-
Abstract 1642: Rare missense variants in MAP3K14
and ARHGAP27
in men with hereditary prostate cancer.
Cancer Research.
1642-1642.
2012
-
Abstract 5255: Methionine restriction limits prostate tumor cell proliferation.
Cancer Research.
5255-5255.
2012
-
Abstract 5631: The effect of pomegranate extract dose on prostate cancer growth in a carbohydrate restricted mouse xenograft model.
Cancer Research.
5631-5631.
2012
-
Abstract LB-423: Whole genome comparisons of pre- and post- aromatase inhibitor treatment in estrogen receptor positive breast cancer.
Cancer Research.
2012
-
P4-10-10: Breast Cancer Risk Factors among Asian Versus Caucasian Women with BRCA1/2 Mutations..
Cancer Research.
2011
-
P4-12-15: Cancer Survivor Care: An Evaluation of a Group Visit Model of Care for Breast Cancer Survivors at Duke Cancer Center..
Cancer Research.
2011
-
P5-13-17: Multigene Signature Assays in Patients with Early-Stage Breast Cancer (ESBC) Receiving Neoadjuvant Chemotherapy: An NCI-Funded Systematic Review and Evidence Summary of Predictive Performance..
Cancer Research.
2011
-
Abstract 3182: PTM ELISA microarray for breast cancer biomarker discovery.
Cancer Research.
3182-3182.
2011
-
Abstract 5377: A role for Ctr1 in the synergistic interaction between mild hyperthermia and cisplatin treatment.
Cancer Research.
5377-5377.
2011
-
Abstract 5569: The association between statin use and risk of biochemical recurrence in men treated with radical prostatectomy in a cohort of men with inherited forms of prostate cancer.
Cancer Research.
5569-5569.
2011
-
Abstract PD06-09: Sentinel Node Biopsy Versus Axillary Lymph Node Dissection in Early-Stage Breast Cancer: A Meta-Analysis of Randomized Controlled Trials.
Cancer Research.
2010
-
Abstract LB-360: Fluorescence-based co-registration with protein markers reveals distinct cellular compartments for altered microRNA expression in solid tumors.
Cancer Research.
2010
-
Abstract LB-76: A study of neoadjuvant bevacizumab with standard chemoradiation versus chemoradiation alone in locally advanced rectal cancer.
Cancer Research.
2010
-
Abstract A10: Antiangiogenic therapy (VEGF-R1–3 and PDGFR inhibitor) increases tumor hemoglobin saturation and decreases interstitial pressure, and microvessel density.
Molecular Cancer Therapeutics.
A10-A10.
2009
-
Abstract A7: Targeting the tumor microenvironment via
inhibition of VEGF and PDGF to improve liposomal drug delivery in human non-small cell lung cancer xenografts.
Molecular Cancer Therapeutics.
A7-A7.
2009
-
Abstract B264: IC261 induces cell cycle arrest and apoptosis of human cancer cells via a CK1δ/ε independent mechanism.
Molecular Cancer Therapeutics.
B264-B264.
2009